Form 4: Exponent CEO Exercises Options, Sells Shares

Exponent Inc.'s President & CEO, Catherine Corrigan, reported exercising stock options and selling a portion of her common stock holdings under a pre-arranged 10b5-1 plan.

Summary

• Catherine Corrigan, President & CEO and Director of Exponent Inc. (EXPO), reported transactions on January 15, 2026.
• She acquired 2,380 shares of common stock by exercising non-qualified stock options at a price of $29.05 per share.
• Concurrently, she disposed of 1,663 shares of common stock at a price of $72.5158 per share.
• Following these transactions, her direct beneficial ownership of common stock is 92,723 shares.
• She also holds 16,658 non-qualified stock options, which become exercisable in four equal annual installments.
• The reported transactions were made pursuant to a Rule 10b5-1(c) contract, instruction, or written plan.

Sentiment

Score: 5

Explanation: The sentiment is neutral. This is a routine insider transaction, likely pre-planned, and does not convey new positive or negative information about the company's operational or financial performance. It reflects personal financial management by an executive.

Positives

• The exercise of stock options indicates the insider is realizing value from previously granted equity awards.
• The sale price of $72.5158 per share is significantly higher than the exercise price of $29.05, indicating a profitable transaction for the insider.

Negatives

• The sale of 1,663 shares reduces the insider's direct common stock holdings, which could be interpreted as a slight reduction in direct exposure to the company's equity.

Risks

• No specific risks to the company's operations or financial health are mentioned in this Form 4 filing. The transaction itself is a routine insider filing.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This is a routine insider transaction filing and does not provide specific insights into broader industry trends or competitive landscape. It reflects an individual executive's personal financial management related to their equity compensation.

Comparison to Industry Standards

• Insider transactions, particularly those executed under Rule 10b5-1 plans, are common across publicly traded companies as a mechanism for executives to manage their equity holdings in a compliant manner.
• The exercise of options and subsequent sale of shares is a standard practice for executives to realize value from their compensation and manage personal finances, including tax obligations or diversification.

Corporate Governance

Stakeholder Impact

• Shareholders: This is a routine insider transaction and is unlikely to have a significant direct impact on the company's share price or long-term value. It provides transparency into executive compensation realization.
• Employees: No direct impact on employees is indicated by this filing.

Next Steps

• The remaining 16,658 non-qualified stock options will continue to vest and become exercisable in future annual installments, as per their original terms.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction (exercise of options and sale of shares) conducted under a pre-arranged 10b5-1 plan. It does not provide new material information about Exponent Inc.'s operational performance, financial health, or strategic direction. Therefore, it does not warrant a change in investment recommendation based solely on this filing. Investors should continue to evaluate the company based on its fundamental performance and broader market conditions.

Keywords

Exponent Inc., EXPO, Catherine Corrigan, Insider Trading, Form 4, Stock Options, 10b5-1 Plan, Equity Compensation, Beneficial Ownership